Intra-day tips from Geojit BNP Paribas; Buy NIIT, TRF, RPG Life Sciences

Here are a few intra-day trading strategies from Geojit BNP Paribas for trade today:

NIIT: BUY
LAST CLOSE: Rs 102.60

Support at Rs 100.50 below Rs 99.20. Resistance is at Rs 103.75 above Rs 105. (Buy for intraday with a stoploss below Rs 99.20)

[VOLUME JUMP + MACD & STOCHASTICS BUY + ABV MOVING AVERAGES + NEW HIGH]

RPG LIFE SCIENCES: BUY
LAST CLOSE: Rs 203.55

Support at Rs 199 below Rs 196.30. Resistance is at Rs 206.75 above Rs 211. (Buy for intraday with a stoploss below Rs 196.30)

[ABV MOVING AVERAGES + MACD & STOCHASTICS BUY + VOLUME JUMP]
 
KANORIA CHEMICALS & INDUSTRIES: BUY
LAST CLOSE: Rs 57.90

Support at Rs 55.50 below Rs 53.25. Resistance is at Rs 60 above Rs 62.75. (Buy for intraday with a stoploss below Rs 53.25)

[VOLUME JUMP + MACD & STOCHASTICS BUY + ABV MOVING AVERAGES]

SRIKALAHASTHI PIPES: BUY
LAST CLOSE: Rs 309.70

Support at Rs 302 below Rs 297. Resistance is at Rs 315 above Rs 319.25. (Buy for intraday with a stoploss below Rs 297)

[STOCHASTICS BUY + VOLUME JUMP + ABV PREVIOUS CLOSE + ABV 50 DMA]

TRF: BUY
LAST CLOSE: Rs 285.25

Support at Rs 283 below Rs 279. Resistance is at Rs 288.90 above Rs 300. (Buy for intraday with a stoploss below Rs 279)

[VOLUME JUMP + ABV 50 DMA + MACD & STOCHASTICS BUY]

Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.